Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of “Hold” by Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned a consensus recommendation of “Hold” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $12.6667.

Several research analysts recently weighed in on the company. Canaccord Genuity Group decreased their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday. Barclays lowered their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th. Finally, Zacks Research lowered shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total value of $183,609.35. Following the transaction, the chief executive officer directly owned 494,011 shares in the company, valued at $1,595,655.53. The trade was a 10.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 4.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

A number of institutional investors have recently bought and sold shares of the stock. Nisa Investment Advisors LLC raised its holdings in Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after buying an additional 4,390 shares during the period. SBI Securities Co. Ltd. boosted its holdings in shares of Aspen Aerogels by 67.3% in the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after buying an additional 2,551 shares during the period. Acadian Asset Management LLC acquired a new position in shares of Aspen Aerogels in the first quarter worth about $43,000. Tower Research Capital LLC TRC increased its position in shares of Aspen Aerogels by 184.6% in the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after acquiring an additional 4,693 shares in the last quarter. Finally, Olympiad Research LP acquired a new stake in shares of Aspen Aerogels during the third quarter valued at approximately $70,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Trading Up 0.5%

Aspen Aerogels stock opened at $3.32 on Thursday. Aspen Aerogels has a 12-month low of $2.92 and a 12-month high of $14.30. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The stock has a market capitalization of $273.98 million, a PE ratio of -0.89 and a beta of 2.95. The firm has a 50 day simple moving average of $5.67 and a 200-day simple moving average of $6.39.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The firm had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.The business’s revenue for the quarter was down 37.8% on a year-over-year basis. During the same quarter last year, the company earned ($0.17) earnings per share. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. As a group, equities research analysts expect that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.